Articles: 25.22 19 November 2014

A prescription for improvement and the dispensing practice scheme

In our series on the history of prescribing policy, Professor Darrin Baines traces how successive governments have attempted to curb drug costs. Here, he describes the impact of A Prescription for Improvement and the renegotiation of arrangements for dispensing doctors.
A prescription for improvement and the …

More details...

Alogliptin – a new DPP-4 inhibitor for type 2 diabetes

Alogliptin (Vipidia), the latest DPP-4 inhibitor, is licensed as second-line therapy in patients with type 2 diabetes mellitus. Steve Chaplin presents the data relating to its efficacy and adverse events and Azhar Farooqi outlines its place in therapy.
Alogliptin a new DPP 4 inhibitor for type …

More details...

Antibiotics: it’s time to get a GRIP

Let’s get one thing clear, for the vast majority of cases seen in primary care, use of antibiotics for simple respiratory tract infections such as sore throats, colds and flu, acute cough and acute otitis media, does not give benefit and may cause harm.
Antibiotics it’s …

More details...

Current management options and recent advances in IBD

The advent of biological therapies has revolutionised the management of inflammatory bowel disease, and the imminent introduction of anti-adhesion molecule therapy seems likely to have a big impact. Our Drug review outlines the current treatment options and examines some recent advances in diagnosis and management, …

More details...

Hair loss in a 16-year-old girl

A 16-year-old girl presented with gradually increasing hair loss and thinning. She had noticed thinning all over her scalp, with visible areas of complete hair loss along the hairline at the temples and back of the scalp during the previous year.
Hair loss in a 16 …

More details...

New from NICE

This long-awaited update to the 2003 clinical guideline covers diagnosis, information and support, treatment of relapse and management of multiple sclerosis (MS) related symptoms in adults in primary and secondary care.
New from NICE

More details...

Once-daily inhaled steroid/LABA combination better than steroid alone

Fluticasone furoate plus vilanterol in inhaled form (FF/VI) reduced both the risk and rate of severe asthma exacerbations (number needed to treat, NNT = 33 for one year) compared with FF alone. The primary potential advantage of this drug over other steroid/long-acting beta- 2 agonist …

More details...

Properties and use of SSRIs for depressive disorders

Steve Chaplin and Dr Rajeev Krishnadas provide an overview of SSRIs – the first-choice medications for the treatment of depressive, obsessive compulsive and anxiety disorders.
Properties and use of SSRIs for depressive disorders

More details...

Understanding can lead to a solution for non-adherence

There are a variety of reasons for non-adherence, both intentional and unintentional, it is therefore important to understand these reasons if we are to tackle the problem.
Understanding can lead to a solution for non adherence

More details...

Web design and marketing agency Leamington Spa